Recently, adjuvant recombinant human IL-7 (rhIL-7) was demonstrated to be effective in sustaining CD4+ recovery in HIV-positive patients with different degrees of immune deficiency [28], [29]. The gene discussed is CD4; the disease is Immunodeficiency.